Nascent Biotech, Inc.
NBIO
$0.0007
-$0.0001-12.50%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.92M | -2.09M | -2.09M | -2.73M | -2.04M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 145.50K | 377.90K | 761.40K | 1.37M | 1.51M |
| Total Other Non-Cash Items | 503.10K | 359.90K | -67.70K | -31.80K | -1.07M |
| Change in Net Operating Assets | -71.90K | 163.80K | 178.50K | -125.60K | -800.00 |
| Cash from Operations | -1.35M | -1.19M | -1.22M | -1.51M | -1.61M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 225.00K | 225.00K | 225.00K | 0.00 | 1.69M |
| Total Debt Repaid | -400.00K | -400.00K | -400.00K | -100.00K | -275.00K |
| Issuance of Common Stock | 1.56M | 1.56M | 1.46M | 1.44M | 60.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -2.00K |
| Cash from Financing | 1.39M | 1.39M | 1.29M | 1.34M | 1.47M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.00K | 200.00K | 65.10K | -177.90K | -136.10K |